China Universal Asset Management Co., Ltd. Amicus Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 63,358 shares of FOLD stock, worth $608,870. This represents 0.06% of its overall portfolio holdings.
Number of Shares
63,358
Previous 57,044
11.07%
Holding current value
$608,870
Previous $609,000
2.13%
% of portfolio
0.06%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding FOLD
# of Institutions
311Shares Held
312MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$277 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$270 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$234 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$230 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$223 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.7B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...